Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Current Assets (2016 - 2025)

Acro Biomedical has reported Current Assets over the past 10 years, most recently at $14098.0 for Q4 2025.

  • Quarterly results put Current Assets at $14098.0 for Q4 2025, up 177.74% from a year ago — trailing twelve months through Dec 2025 was $14098.0 (up 177.74% YoY), and the annual figure for FY2025 was $14098.0, up 177.74%.
  • Current Assets for Q4 2025 was $14098.0 at Acro Biomedical, up from $4323.0 in the prior quarter.
  • Over the last five years, Current Assets for ACBM hit a ceiling of $920256.0 in Q1 2021 and a floor of $151.0 in Q1 2024.
  • Median Current Assets over the past 5 years was $282893.0 (2023), compared with a mean of $337879.9.
  • Biggest five-year swings in Current Assets: tumbled 99.98% in 2024 and later soared 4179.27% in 2025.
  • Acro Biomedical's Current Assets stood at $706415.0 in 2021, then decreased by 6.92% to $657537.0 in 2022, then plummeted by 99.75% to $1626.0 in 2023, then surged by 212.18% to $5076.0 in 2024, then skyrocketed by 177.74% to $14098.0 in 2025.
  • The last three reported values for Current Assets were $14098.0 (Q4 2025), $4323.0 (Q3 2025), and $39626.0 (Q2 2025) per Business Quant data.